TAE focuses on nuclear fusion, a technology that combines two light atomic nuclei to form a single heavier one. It releases ...

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...